David Barrett continues a discussion with Rob Matheis on how medical congresses can deliver value and opportunities for everyone.
Creators of Industry Voice share tips on how to leverage video content to generate discussion among experts, engage viewers, and build brand value.
Find out what’s in the new CONSORT-ROUTINE checklist for randomised controlled trials using cohorts and routinely collected data.
Why loss of confidence in previously published findings does not necessarily lead to self-correction of the scientific record
A new study looks at why researchers may question their past conclusions and how likely they are to disclose this publicly.
Avishek Pal discusses the development and launch of the ISMPP Authorship Algorithm.
How are medical societies innovating in the face of a changing medical conference landscape? David Barrett (CEO of the American Society of Gene & Cell Therapy) spoke with Rob Matheis to explain.
Read Brian Southwell’s perspective on what can be done to prevent misinformation and build public trust in science.
Len Starnes discusses how medical societies have integrated digital approaches into their conferences.
Detectives are on the hunt for fake research papers: Nature analysis investigates the paper mill problem
Nature analyses the ongoing battle publishers are facing against paper mills and what editors are doing to identify these fake articles.
Open access publishing seeks to improve equity, but article processing charges may have the opposite effect
A recent study found that authors with certain characteristics are more likely to publish open access, potentially leading to bias.
Find out more about what the open access training modules cover.
Listen to Jenny Ghith discuss innovative forms of digital communication.
Study reveals that Altmetric Attention Score used to assess the online impact of an article is not influenced by author’s gender.
We’ve heard of open data, but should we also consider open methods as standard?
Analysis of Elsevier’s article metadata and invoicing information provides insights into the uptake of hybrid open access.
European countries can’t agree on what counts as research misconduct, creating potential pitfalls for researchers.